Medical News

RSS

Tips to help ensure best plastic surgery results

Believe it or not, you play just as big a role in the overall success of your cosmetic surgery as your surgeon. Board certified plastic surgeon Dr. Gregory A. Buford recently published a comprehensive list of tips to help ensure the best results, no matter what procedure you're preparing for.

29 Mar 2012

Top-five pharma manufacturer implements ALSCG MemberMATCH GPO solution

Alliance Life Sciences Consulting Group, a leading management and technology consultancy, announces the implementation of MemberMATCH at a top-five pharmaceutical manufacturer.

29 Mar 2012

Sientra closes $65M Series C financing

Sientra, a privately-held medical device company focused on the aesthetic and plastic surgery markets, announced today that it closed on its $65 million Series C financing led by Abingworth and with participation by Clarus Ventures, OrbiMed Advisors and all other insiders.

29 Mar 2012

Perspectives on health law challenge: Does court recognize its own limits?; A dubious link to Civil Rights Act; The burden on young people

In ruling on the constitutionality of requiring most Americans to obtain health insurance, the Supreme Court faces a central test: whether it will recognize limits on its own authority to overturn well-founded acts of Congress.

29 Mar 2012

Affymetrix' GeneChip technology incorporated into Lineagen's FirstStepDx genetic evaluation service

Affymetrix, Inc. and Lineagen, Inc., an innovative molecular diagnostics company focused on complex, genetically linked disorders, today announced the companies have signed an agreement to incorporate Affymetrix' GeneChip technology into Lineagen's next-generation FirstStepDx, a genetic evaluation service for individuals with developmental delay (DD), intellectual disability (ID), and autism spectrum disorders (ASD).

29 Mar 2012

P. falciparum colonizes America via two separate introduction routes: Study

The malaria parasite, Plasmodium falciparum, originates from Africa, and is found on every continent. Over 200 million people are infected every year from Africa to Asia, as well as in America and the Middle East. How did it spread to the entire planet? It is not entirely clear how it conquered the New World. Scientists from the UMR Migevec and their partners have recently shown in the journal PNAS that the pathogen was introduced by ship during the slave trade.

29 Mar 2012

FDA clears BD MAX assay for detecting GBS DNA in Lim Broth cultures

BD announced today the U.S. Food and Drug Administration clearance of the BD MAX Group B Streptococcus (GBS) Assay and Clinical Laboratory Improvement Amendments (CLIA) moderate complexity test categorization on the second-generation BD MAX System.

From BD (Becton, Dickinson and Company) 29 Mar 2012

BCBSMF launches Connect for Health Challenge

The Blue Cross and Blue Shield of Minnesota Foundation today announced the launch of the Connect for Health Challenge, a new grantmaking initiative that will award up to $500,000 to eligible nonprofits, schools and local units of government to support efforts that strengthen social connections in low-income communities across Minnesota.

29 Mar 2012

Althea provides Allena exclusive worldwide rights to broad hyperoxaluria portfolio

Allena Pharmaceuticals, Inc., and Althea Technologies today announced a licensing agreement under which Allena has obtained the exclusive worldwide rights to Althea's broad hyperoxaluria portfolio including product patents, regulatory information and development data related to oxalate degrading enzymes.

29 Mar 2012

Amerigroup announces successful efforts at preventing premature births

Amerigroup Corporation announced its successful efforts at preventing premature births – as well its commitment to protecting access to affordable drug therapies for at-risk mothers – at the annual Norfolk/Virginia Beach March of Dimes kick-off breakfast for the March for Babies.

29 Mar 2012

Galectin closes underwritten public offering of 1,333,361 units

Galectin Therapeutics Inc. today announced it has closed its underwritten public offering of 1,333,361 units (including 173,916 units that were offered and sold by Galectin pursuant to the exercise in-full of the underwriter's over-allotment option) at a price to the public of $9.00 per unit, with each unit consisting of two common voting shares, par value $0.001 per share and one warrant to purchase one share of Common Stock.

29 Mar 2012

CDC Director provides update on AIDS epidemic in anticipation of AIDS 2012 conference

In anticipation of the AIDS 2012 conference, to be held in Washington, D.C., from July 22-27, CDC Director Thomas Frieden spoke at the Washington-based Center for Strategic & International Studies, where he provided an update on the epidemic in the U.S. and abroad, VOA News reports.

29 Mar 2012

AFB announces Access Award recipients for 2012

What do the leaders of "America's pastime," a free open-source screen-reading software company, an orientation and mobility (O&M) program, and the founder of Camp Abilities have in common? All have taken successful strides toward creating a better quality of life for people who are blind or visually impaired, which is why they were named the recipients of the 2012 Access Awards, announced today by the American Foundation for the Blind.

29 Mar 2012

Many medical implants never tested for safety

A new investigation by Consumer Reports reveals that while tens of millions of American consumers live with medical devices implanted in their bodies, many of these implants have never been tested for safety and manufacturers are often required to do nothing more than file paperwork and pay a user fee before bringing their products to market.

29 Mar 2012

MabCure retains CUNY CAT to evaluate monoclonal antibodies against ovarian cancer

MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.

29 Mar 2012

Stem Cells reports results of Neuralstem ALS Phase I trial

Neuralstem, Inc. announced that safety results from the first 12 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) to receive its stem cells were reported online in the peer-reviewed publication, Stem Cells, on March 13th.

29 Mar 2012

Greenway announces availability of PrimeMOBILE

Greenway Medical Technologies, Inc. today announced the availability of its remote clinical and financial solution PrimeMOBILE as a native application for download onto Android smartphone and tablet devices.

29 Mar 2012

UICOMP to join provider network of Coventry Health Care

Effective April 1, 2012, the University of Illinois College of Medicine at Peoria will join the provider network of Coventry Health Care of Illinois, Inc. to serve area members.

29 Mar 2012

IMRT associated with reduced toxicities when compared with standard whole breast irradiation

Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Radiation Oncology (PRO), the official clinical practice journal of the American Society for Radiation Oncology (ASTRO).

29 Mar 2012

Meditation decreases depression, anxiety and stress in school teachers

Schoolteachers who underwent a short but intensive program of meditation were less depressed, anxious or stressed - and more compassionate and aware of others' feelings, according to a UCSF-led study that blended ancient meditation practices with the most current scientific methods for regulating emotions.

29 Mar 2012